Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area.
Journal Article (Multicenter Study;Journal Article)
We implemented universal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing of patients undergoing surgical procedures as a means to conserve personal protective equipment (PPE). The rate of asymptomatic coronavirus disease 2019 (COVID-19) was <0.5%, which suggests that early local public health interventions were successful. Although our protocol was resource intensive, it prevented exposures to healthcare team members.
Full Text
Duke Authors
- Cardona, Diana Marcella
- Datto, Michael Bradley
- Denny, Thomas Norton
- Kalu, Ibukun Christine
- Lee, Mark Jae
- Lewis, Sarah Stamps
- Lobaugh, Bruce
- Martin, Gavin
- Rehder, Rebeccah Catherine
- Seidelman, Jessica
- Wolfe, Cameron Robert
Cited Authors
- Lewis, SS; Smith, BA; Akinboyo, IC; Seidelman, J; Wolfe, C; Kirk, AB; Martin, G; Denny, T; Lobaugh, B; Rehder, C; Cardona, D; Lee, MJ; Polage, CR; Datto, MB
Published Date
- March 2021
Published In
Volume / Issue
- 42 / 3
Start / End Page
- 341 - 343
PubMed ID
- 32741409
Pubmed Central ID
- PMC7450245
Electronic International Standard Serial Number (EISSN)
- 1559-6834
International Standard Serial Number (ISSN)
- 0899-823X
Digital Object Identifier (DOI)
- 10.1017/ice.2020.398
Language
- eng